Session » Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Autoinflammatory Disorders and Miscellaneous
- 9:00AM-11:00AM
-
Abstract Number: 374
A Pilot Study of Infrared Thermal Imaging to Detect Active Bone Lesions in Children with Chronic Nonbacterial Osteomyelitis
- 9:00AM-11:00AM
-
Abstract Number: 373
a Retrospective Study of Clinical Factors Influencing the Development of Overlapping Disease Features in Pediatric Patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Spondyloarthropathies (SpA)
- 9:00AM-11:00AM
-
Abstract Number: 386
Analysis of the Effectiveness of Immunization with Pneumococcal Polysaccharide Vaccine in Children with Juvenile Idiopathic Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 364
Canakinumab First or Second Choice in Systemic Juvenile Idiopathic Arthritis – Experience from Clinical Practice
- 9:00AM-11:00AM
-
Abstract Number: 365
Canakinumab Treatment in Patients with Still’s Disease: A Pooled Analysis of Systemic Juvenile Idiopathic Arthritis Data By Age Groups
- 9:00AM-11:00AM
-
Abstract Number: 375
Controlled Discontinuation of Colchicine Therapy in Familial Mediterranean Fever Patients with Single MEFV Mutation
- 9:00AM-11:00AM
-
Abstract Number: 381
Down’s Arthritis (DA) – Clinical and Radiological Features of Arthritis in Children with Trisomy 21
- 9:00AM-11:00AM
-
Abstract Number: 368
Evaluation of Efficacy and Safety of Opocalcium Colchicine, and Anti-IL1 Treatment in Childhood Colchicine-Resistant Familial Mediterranean Fever
- 9:00AM-11:00AM
-
Abstract Number: 379
H Syndrome: Five New Cases from the United States with Novel Features and Responses to Therapy
- 9:00AM-11:00AM
-
Abstract Number: 369
Hepatitis A Virus Vaccination in Juvenile-Onset Systemic Lupus Erythematosus
- 9:00AM-11:00AM
-
Abstract Number: 383
Immunogenicity of 13 Valent Pneumococcal Vaccine in Children with Lupus: Single Center Experience in South Texas
- 9:00AM-11:00AM
-
Abstract Number: 376
Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial
- 9:00AM-11:00AM
-
Abstract Number: 367
Interleukin-1 Receptor Antagonist Is a Potential Treatment for Undifferentiated Autoinflammatory Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 371
Longer Term Outcomes of Chronic Relapsing Multifocal Osteomyelitis in a UK Tertiary Adolescent and Young Adult Rheumatology Centre
- 9:00AM-11:00AM
-
Abstract Number: 378
Musculoskeletal Features in Copa Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 377
Novel Insights into Periodic Fever Syndromes
- 9:00AM-11:00AM
-
Abstract Number: 372
Phenotype of Chronic Recurrent Multifocal Osteomyelitis in a Tertiary Referral Centre: The Great Ormond Street Hospital Experience
- 9:00AM-11:00AM
-
Abstract Number: 384
Protection Against Hepatitis B in Immunocompromised Pediatric Rheumatology and Gastroenterology Patients
- 9:00AM-11:00AM
-
Abstract Number: 382
Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 385
Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients
- 9:00AM-11:00AM
-
Abstract Number: 366
Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom
- 9:00AM-11:00AM
-
Abstract Number: 380
Treatment Outcomes of Down Syndrome Arthropathy